Medical statistics can be daunting. Understanding them is essential to understand any research paper. Here are some basic in medical statistics by Dr Vivek Baliga, Consultant Internal Medicine, Bangalore. Read more by Dr Vivek Baliga at http://drvivekbaliga.net
The ppt is a short description about how to ascertain the validity, ie; sensitivity and specificity of a screening test as well as their predictive powers. you can also find the technique to ascertain the best possible screening test through the help of an ROC curve...
The ppt is a short description about how to ascertain the validity, ie; sensitivity and specificity of a screening test as well as their predictive powers. you can also find the technique to ascertain the best possible screening test through the help of an ROC curve...
Commonly Used Statistics in Medical Research Part IPat Barlow
This presentation covers a brief introduction to some of the more common statistical analyses we run into while working with medical residents. The point is to make the audience familiar with these statistics rather than calculate them, so it is well-suited for journal clubs or other EBM-related sessions. By the end of this presentation the students should be able to: Define parametric and descriptive statistics
• Compare and contrast three primary classes of parametric statistics: relationships, group differences, and repeated measures with regards to when and why to use each
• Link parametric statistics with their non-parametric equivalents
• Identify the benefits and risks associated with using multivariate statistics
• Match research scenarios with the appropriate parametric statistics
The presentation is accompanied with the following handout: http://slidesha.re/1178weg
This PPT discusses
Basics measurements in epidemiology
Basics requirements of measurements
Tools of measurements
Measures of morbidity
Measures of disability
Measures of mortality
A non technical overview of sample size calculation and why it is necessary with some brief examples of how to approach the problem and why it is useful to actually think of these calculations.
In order to understand medical statistics, you have to learn the very basic concepts as mean, median, and standard deviation. interpretation and understanding of clinical study results depends mainly on statistical background.
Presented by N..SRIIKANTH, ASST..DIIRECTOR (AY) & G.S.LAVEKAR,
DIIRECTOR, CENTRAL COUNCIL FOR RESEARCH IN AYURVEDA AND SIDDHA
Department of AYUSH, Ministry of Health & Family Welfare, Govt. of India
I like this presentation to read by others
Commonly Used Statistics in Medical Research Part IPat Barlow
This presentation covers a brief introduction to some of the more common statistical analyses we run into while working with medical residents. The point is to make the audience familiar with these statistics rather than calculate them, so it is well-suited for journal clubs or other EBM-related sessions. By the end of this presentation the students should be able to: Define parametric and descriptive statistics
• Compare and contrast three primary classes of parametric statistics: relationships, group differences, and repeated measures with regards to when and why to use each
• Link parametric statistics with their non-parametric equivalents
• Identify the benefits and risks associated with using multivariate statistics
• Match research scenarios with the appropriate parametric statistics
The presentation is accompanied with the following handout: http://slidesha.re/1178weg
This PPT discusses
Basics measurements in epidemiology
Basics requirements of measurements
Tools of measurements
Measures of morbidity
Measures of disability
Measures of mortality
A non technical overview of sample size calculation and why it is necessary with some brief examples of how to approach the problem and why it is useful to actually think of these calculations.
In order to understand medical statistics, you have to learn the very basic concepts as mean, median, and standard deviation. interpretation and understanding of clinical study results depends mainly on statistical background.
Presented by N..SRIIKANTH, ASST..DIIRECTOR (AY) & G.S.LAVEKAR,
DIIRECTOR, CENTRAL COUNCIL FOR RESEARCH IN AYURVEDA AND SIDDHA
Department of AYUSH, Ministry of Health & Family Welfare, Govt. of India
I like this presentation to read by others
MedicReS Winter School 2017 Vienna - Importance of Selection of Outcomes - Ma...MedicReS
Importance of Selection of Outcomes and Covariates in Comparative Effectiveness of Cancer ...
International Conference Good Biostatistical and Publication Practice in Cancer Research with “Real Work Data”
February 13-14th, Vienna
Mariana Chavez Mac GregorMD, MSc.
Assistant Professor, Health Services Research Department
Breast Medical Oncology Department
Screening is an essential concept in the field of Medicine, specially in Preventive Medicine. This presentation covers the essentials to understand Screening of Diseases.
Chapter 2
Study Designs
Learning Objectives
• List and define the components of a good
study design
• Compare and contrast observational and
experimental study designs
• Summarize the advantages and disadvantages
of alternative study designs
Learning Objectives
• Describe the key features of a randomized
controlled trial
• Identify the study designs used in public health
and medical studies
Study Designs
• Observational Studies
– Case-series study
– Cross-sectional (prevalence) survey
– Case-control study
– Cohort study
• Experimental Studies
– Randomized Controlled (Clinical) Trial
Inferences
• Observational studies – inferences limited to descriptions
and associations; with carefully designed analysis can
make stronger inferences (statistical adjustment)
• Experimental studies – cause and effect
In ALL studies – need careful definition of disease
(outcome) and exposure (risk factor)
Which Design is Best
• Depends on the study question
• What is current knowledge on topic
• How common is disease (and risk factors)
• How long would study take, what are costs
• Ethical issues
Case Report/Case Series
• Observational study
• Case report: Detailed report of specific
features of case
• Case series: Systematic review of common
features of a small number of cases
• Advantage: Cost-efficient
• Disadvantages: No comparison group, no
specific research question
Case-Series
• Simplest design – description of interesting
observations in a small number of individuals
• Usually case-series do not involve control patients
(i.e., patients free of disease)
• Usually lead to generation of hypotheses for more
formal testing
• Criticisms: not planned – no research hypotheses
Case-Series
• Gottleib (1981) studied 5 young homosexual
men with rare form of pneumonia and other
unusual infections
• Initial report was followed by more series (26
cases in NY and CA; “cluster” in southern CA;
34 cases among Haitians, etc.)
• Condition termed AIDS in 1982
Cross-Sectional Survey
• Observational study conducted at a point in
time
• Advantages: Cost-efficient, easy to implement,
ethical
• Disadvantages: No temporal information, non-
response bias
Cross-Sectional Survey
• Is there an association between diabetes and
cardiovascular disease (CVD)?
Patients
with
Diabetes
Patients without
Diabetes
Patients with
CVD
Prospective Cohort Study
• Observational study involving a group (cohort)
of individuals who meet inclusion criteria
followed prospectively in time for risk factor
and outcome information
• Advantages: Can assess temporal relationships
• Disadvantages: Need large numbers for rare
outcomes, confounding
Cohort Study
• Is there an association between hypertension and
cardiovascular disease?
CVD
Hypertension
No CVD
Cohort
CVD
No Hypertension
No CVD
Study Start Time
Cohort Studies
• Identify a group of individuals that meet
inclusion crit ...
Dr Vivek Baliga discusses left atrial myxoma for medical students. Lecture includes a link to MCQs in the video. For access to video, please copy and paste this link --> https://youtu.be/JtkWxbVklgA
White Coat Hypertension - Dr Vivek Baliga Patient PresentationDr Vivek Baliga
Dr Vivek Baliga discusses in brief the problem of white coat hypertension - what it means, how it can be a problem and what steps can be taken to lower future risk of hypertension.
Stomach Bloating And Acidity - Tips To Rid Yourself Of It - Dr Vivek Baliga P...Dr Vivek Baliga
Dr Vivek Baliga, physician and internal medicine specialist at Baliga Diagnostics, discusses stomach bloating and how acidity related symptoms can be treated with some simple steps.
Visit his LinkedIn profile here - https://www.linkedin.com/in/dr-vivek-baliga-7b59b0125/
Lower blood pressure without medicines - Dr Vivek Baliga Patient GuideDr Vivek Baliga
Dr Vivek Baliga, physician, discusses simple ways to lower elevated blood pressure naturally using simple lifestyle measures. For more information on Dr Vivek, visit his online profile here - http://baligadiagnostics.com/dr-vivek-baliga/
Consultant Internal Medicine Dr Vivek Baliga reviews a common medical problem - frozen shoulder. It is simple to treat but carries a significant morbidity if ignored. Aimed at medical students.
Dr Vivek Baliga Review - Case Of A Rash On The HipsDr Vivek Baliga
This is an interesting case and one for medical students to be used as a review. Starts with a case and followed by Dr Vivek Baliga's review on the diagnosis with references.
Losing Weight For Unexplained Reasons - Dr Vivek Baliga Patient PresentationDr Vivek Baliga
Weight loss is a serious problem, especially if it happens without any effort. Here are some common reasons why it might be happening. Full text article - http://heartsense.in/losing-weight-for-no-reason-heres-why/
Combination Therapy In Hypertension - Dr Vivek Baliga PresentationDr Vivek Baliga
Dr Vivek Baliga of Baliga Diagnostics, Bangalore, discusses the common combination therapies used in the management of hypertension in clinical practice.
Newer Oral Anticoagulants In Atrial Fibrillation - Dr Vivek BaligaDr Vivek Baliga
In this presentation, Dr Vivek Baliga, Baliga Diagnostics Bangalore, discusses the role of new oral anticoagulants in the management of non-valvular atrial fibrillation.
Author Profile - http://baligadiagnostics.com/dr-vivek-baliga/
In this presentation, Dr Vivek Baliga discusses some of the common cardiac conditions that are seen in post menopausal women.
Dr VIvek Baliga discusses the management of irritable bowel syndrome in the second part of this presentation. For more information on health and heart disease, visit http://heartsense.in/author/dr-vivek-baliga-b/
ECG In Ischemic Heart Disease - Dr Vivek Baliga ReviewDr Vivek Baliga
Dr Vivek Baliga Presentation on the role of ECG in the diagnosis of ischemic heart disease. Here, he covers the very basics in ECG diagnosis of heart disease. Suitable for medical students and physicians alike. For more health articles for patients, visit http://baligadiagnostics.com/category/dr-vivek-baliga/
Link to article - http://heartsense.in/what-enlarged-prostate-gland/
Dr Vivek Baliga discusses why the prostate gland enlarges, what it means and how it can be managed. Patient presentation.
For academic articles, visit http://drvivekbaliga.net
Irritable Bowel Syndrome Part 1 - Dr Vivek BaligaDr Vivek Baliga
In this presentation, Dr Vivek Baliga discusses the important aspects of irritable bowel syndrome - a common medical problem in clinical practice. For more articles, visit http://baligadiagnostics.com/author/drbvb/
Post viral pericarditis - Dr Vivek Baliga presentationDr Vivek Baliga
Dr Vivek Baliga Academic Summaries - http://drvivekbaliga.net
Patient articles - http://heartsense.in/author/dr-vivek-baliga-b/
In this presentation, you will learn about post viral pericarditis in brief.
Dr Vivek Baliga - Diastolic heart failure - A complete overviewDr Vivek Baliga
In this presentation, Dr Vivek Baliga, Consultant Internal Medicine, discusses a common problem in medical practice that often confuses many - diastolic heart failure. Now a misnomer, it is referred to as heart failure with preserved ejection fraction. For patient articles - http://heartsense.in/author/dr-vivek-baliga-b/ . LinkedIn - https://www.linkedin.com/in/dr-vivek-baliga-7b59b0125
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And DiabetesDr Vivek Baliga
Dr Vivek Baliga, Consultant Internal Medicine at Baliga Diagnostics discusses the management of 2 common problems in medical practice - heart failure and type 2 diabetes, including the link between the two. For more articles for patients, visit http://heartsense.in/author/dr-vivek-baliga-b/. For scientific articles and short reviews, visit http://drvivekbaliga.net/
Dyslipidemia management an evidence based approachDr Vivek Baliga
In this presentation by Dr Vivek Baliga, he discusses the different available statins and how you can choose the right one in different clinical situations. See articles from Dr Baliga on http://drvivekbaliga.net
Executive Directors Chat Leveraging AI for Diversity, Equity, and InclusionTechSoup
Let’s explore the intersection of technology and equity in the final session of our DEI series. Discover how AI tools, like ChatGPT, can be used to support and enhance your nonprofit's DEI initiatives. Participants will gain insights into practical AI applications and get tips for leveraging technology to advance their DEI goals.
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
Acetabularia Information For Class 9 .docxvaibhavrinwa19
Acetabularia acetabulum is a single-celled green alga that in its vegetative state is morphologically differentiated into a basal rhizoid and an axially elongated stalk, which bears whorls of branching hairs. The single diploid nucleus resides in the rhizoid.
Dr Vivek Baliga - The Basics Of Medical Statistics
1. Medical Statistics –Medical Statistics –
The BasicsThe Basics
Dr Vivek Baliga BDr Vivek Baliga B
Consultant Internal Medicine,Consultant Internal Medicine,
Baliga Diagnostics Pvt. LtdBaliga Diagnostics Pvt. Ltd
2. What is Statistics?
• Science of collecting, organising and
interpreting numerical facts
• Science of learning from data :
– Design the data collection
– Prepare the data for analysis
– Analyse the data
– Communicate the results of the data
4. Types of data
• Quantitative
(How much?)
– Measured : BP,
Height
– Counted : Attacks
of asthma a week
• Categorical
(What type?)
– Nominal : Sex
(m/f), hair colour
– Ordinal : Grade of
breast Ca
– Binary :
Male/Female,
Dead/alive
5. Measures of Effect
• Describe the measure that is used to
compare treatment effects in 2 or
more comparison groups
6. Measure of Effect
• Quantitative Variables
– Mean
– Median
• Categorical Variables
– Risks
– Odds Ratio
7. • Mean
1+2+3+6+7+12+18 = 49
Mean = 49/7 =7
• Median (Odd number N)
1+2+3+6+7+12+18
Median =6
• Median (Even number N)
2+3+6+7+12+18
Median = 6+7/2 = 6.5
9. Standard Deviation
2+8+10+13+22 = 55
Mean = 55/5 =11
Variance = (2-11)2
+(8-11)2
+(10-11)2
+(13-11)2
+(22-11)2
N-1
= 216/4 = 54
Standard Deviation = √54 = 7.2
10. Standard deviation
• Estimate of variability of
observations
• Larger sample provides a better and
more precise estimate of the
standard deviation.
11. Measures of Effect
• Absolute risk : A/A+C
• Relative Risk :
A/A+C÷B/B+D
• Absolute risk
reduction : A/A+C-
B/B+D
• Number needed to
treat : 1/ARR
D+ D-
Ex+ A B
Ex- C D
A+C B+D
12. Types of studies
• Randomised control trials
• Cohort studies
• Case control studies
• Cross sectional studies
• Case reports
13. Randomised Control
Trials
• Gold standard in medical research
• Best to study cause vs effect
• Various components
– Randomisation
– Blinding
– Controlled
16. Randomised Control
Trials
• Blinding
– Single blind : patient cannot predict
which treatment they get
– Double blind : neither patient nor
investigator knows
– Triple blind : Neither pt, investigator or
person administering treatment (eg
pharmacist) knows
17. Randomised Control
Trials
• Controlled trial
– Placebo controlled : Simvastatin vs
placebo
– Active control : Simvastatin vs
Pravastatin
– Active – placebo –control : Simvastatin
vs pravastatin vs placebo
18. Randomised Control
Trials
• Advantages
– Prospective design
– Rigorous evaluation
of a single variable
– Eradicates bias
– Uses null
hypothesis
• Disadvantages
– Expensive
– Time consuming
19. Cohort studies
• Cohort is a group of people who share a
common characteristic or experience
within a defined time period
• Eg : People born in 1980= birth cohort
• Cohort studies are done to obtain
additional evidence that there is an
association between a suspected cause
and disease.
20. Cohort studies
• Prospective
– Follow up in years
– Can collect confounding factors
– Expensive, time consuming
– E.g.: Framingham heart study
• Retrospective
– Incomplete information
– Confounding factors may not be collected
– Quick, cheap
– E.g.: angiosarcoma in relation to poly-vinyl chloride
21. Cohort studies- Elements
• Selection of subjects
– General population
– Special groups eg: Dolls study of
smoking and lung cancer in British
doctors in 1951
– Exposure groups : eg radiologists and X-
rays
22. Cohort studies- Elements
• Obtaining data
– Interviews/questionnaires – dolls study
– Review of records
– Medical examination and special tests
– Environmental surveys – exposure etc
23. Cohort studies- Elements
• Selection of comparison groups
– Internal – within the cohort
– External – eg radiologists vs
ophthalmologists
– General population
24. Cohort studies- Elements
• Follow up
– Periodic examination - best method
– Questionnaires
– Review of records periodically
25. Cohort studies- Elements
• Analysis
– Incidence rates
– Estimation of risk
• Relative risk
• Attributable risk
26. Cohort studies- Elements
• Incidence rates
– Exposed 70/7000 = 10
per 1000
– Non Exposed 3/3000 =
1 per 1000
• Relative risk =10/1 = 10
• Attributable risk =
[(10-1)/10]x100 = 90%
Cigarette
smoking
Ca + Ca - Total
Yes 70 (a) 6930
(b)
7000
(a+b)
No 3(c) 2997
(d)
3000
(c+d)
27. Cohort studies- Risks
• Relative risk
– Incidence among exposed
Incidence among non exposed
– RR = 1 means no association
– RR > 1 implies ‘positive’ association
– Smokers are 10 times at risk of lung Ca that
non smokers.
28. Cohort studies- Risks
• Attributable risks
– Incidence among exposed-non exposed x100
Incidence among exposed
– Tells us to what extent the disease under study can be
attributed to the exposure.
29. Cohort studies
• Strengths
– Valuable if
exposure is rare
– Examine multiple
effects of an
exposure
– Can measure
incidence of a
disease
• Limitations
– Cannot evaluate
rare diseases
– Expensive and
time consuming if
prospective
– Several losses to
follow up can
effect validity
30. Case Control Study
• Retrospective study
• Both exposure and outcome have
occurred before the start of the
study
• Uses a ‘control’ or comparison group
31. Case Control Study
• Selection of cases and controls
• Matching
• Measurement of exposure
• Analysis and interpretation
33. Case Control Study
• Exposure rates
– Cases a/(a+c) =94.2%
– Controls b/(b+d) = 67%
• Relative risk = a/a+c ÷b/b+d
• Odds ratio = ad/bc = 8.1
– Smokers of < 5/day have a
risk of developing lung cancer
8.1 times that of non-
smokers.
Cases
(with
lung Ca)
Controls
(without
Lung Ca)
Smokers
(<5/day)
33 (a) 55 (b)
Non
Smokers
2(c) 27(d)
Total 35 (a+c) 82 (b+d)
34. Bias in Case Control
Study
• Confounding factors – alcoholism and
oesophageal cancer; smoking is a
confounding factor.
• Recall bias
• Selection bias
• Interviewers bias
35. Cross sectional studies
• ‘Prevalence study’
• Based on a single examination of a
cross section of population at one
point in time.
36. Meta-analysis
• Statistical analysis of the results
from independent studies, which
generally aims to produce a single
estimate of treatment effect.
37. Displaying Data
• Bar Charts
• Histogram
• Line diagrams
• Pie charts
• Scatter plots
• Forest plots